Journey Medical Corp
Presença
Fortress Biotech é uma empresa listada sob o símbolo FBIO (US).
Fortress Biotech possui 4 subsidiárias incluindo Avenue Therapeutics, Checkpoint Therapeutics e Journey Medical Corp.
Eles estão dentro:
- Biotecnologia80%
- Farmacêutica20%
Executivos
Veja o organograma con seus 13 executivos principais
Biografias mais buscadas da Journey Medical Corp
- Claude Maraoui, Director, President and Chief Executive Officer
- Justin Smith, Director
- Miranda Toledano, Director
Recentes movimentos de executivos em Journey Medical Corp
- Jeffrey Paley, Director, deixou a Companhia (Notícia publicada em 11 de dezembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Journey Medical Corp.
Farmacêutica
Fortress Biotech possui 1.867 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Journey Medical Corp
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
- Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
- Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
- Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
- Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
- Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
- Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
- View more press releases Close
Redes sociais sobre Journey Medical Corp
- Journey Medical Corp na Wikipedia, Google News e Yahoo Finance
- Journey Medical Corp na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Claude Maraoui 
Ligue para a Journey Medical Corp em +1 480...
